GRK2在阿尔茨海默病发病机制中的作用(4)
[29]Nunomura A,Perry G,Aliev G,et al.Oxidative damage is the earliest event in Alzheimer disease.J Neuropathol Exp Neurol,2001,60(8):759-767.
[30]Suo Z,Wu M,Citron BA,et al.Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimers disease:an association with early betaamyloid accumulation.J Neurosci,2004,24(13):3444-3452.
[31]Aliev G,Smith MA,Obrenovich ME,et al.Role of vascular hypoperfusioninduced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.Neurotox Res,2003,5(7):491-504.
[32]Aliev G,Seyidova D,Neal ML,et al.Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.Ann N Y Acad Sci,2002,3(977):45-64.
[33]Aliev G,Smith MA,Seyidov D,et al.The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimers disease.Brain Pathol,2002,12(1):21-35.
[34]Aliev G,Smith MA,de la Torre JC,et al.Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimers disease.Mitochondrion,2004,4(5-6):649-663.
[35]Zhu X,Smith MA,Perry G,et al.Mitochondrial failures in Alzheimers disease.Am J Alzheimers Dis Other Demen,2004,19(6):345-352.
[36]de la Torre JC,Aliev G.Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion:spatial memory and immunocytochemical changes.J Cereb Blood Flow Metab,2005,25(3):663-672.
[37]Robinson SR,Bishop GM.Abeta as a bioflocculant:implications for the amyloid hypothesis of Alzheimers disease.Neurobiol Aging,2002,23(6):1051-1072.
[38]Obrenovich ME,Joseph JA,Atwood CS,et al.Amyloid-beta:a(life) preserver for the brain.Neurobiol Aging,2002,23(6):1097-1099.
[39]Hu JH,Zhang H,Wagey R,et al.Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord.J Neurochem,2003,85(2):432-442.
[40]Paris D,Humphrey J,Quadros A,et al.Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimers disease:role of inflammation.Neurol Res,2003,25(6):642-651., 百拇医药(王彦喆,孙景旭)
[30]Suo Z,Wu M,Citron BA,et al.Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimers disease:an association with early betaamyloid accumulation.J Neurosci,2004,24(13):3444-3452.
[31]Aliev G,Smith MA,Obrenovich ME,et al.Role of vascular hypoperfusioninduced oxidative stress and mitochondria failure in the pathogenesis of Azheimer disease.Neurotox Res,2003,5(7):491-504.
[32]Aliev G,Seyidova D,Neal ML,et al.Atherosclerotic lesions and mitochondria DNA deletions in brain microvessels as a central target for the development of human AD and AD-like pathology in aged transgenic mice.Ann N Y Acad Sci,2002,3(977):45-64.
[33]Aliev G,Smith MA,Seyidov D,et al.The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimers disease.Brain Pathol,2002,12(1):21-35.
[34]Aliev G,Smith MA,de la Torre JC,et al.Mitochondria as a primary target for vascular hypoperfusion and oxidative stress in Alzheimers disease.Mitochondrion,2004,4(5-6):649-663.
[35]Zhu X,Smith MA,Perry G,et al.Mitochondrial failures in Alzheimers disease.Am J Alzheimers Dis Other Demen,2004,19(6):345-352.
[36]de la Torre JC,Aliev G.Inhibition of vascular nitric oxide after rat chronic brain hypoperfusion:spatial memory and immunocytochemical changes.J Cereb Blood Flow Metab,2005,25(3):663-672.
[37]Robinson SR,Bishop GM.Abeta as a bioflocculant:implications for the amyloid hypothesis of Alzheimers disease.Neurobiol Aging,2002,23(6):1051-1072.
[38]Obrenovich ME,Joseph JA,Atwood CS,et al.Amyloid-beta:a(life) preserver for the brain.Neurobiol Aging,2002,23(6):1097-1099.
[39]Hu JH,Zhang H,Wagey R,et al.Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord.J Neurochem,2003,85(2):432-442.
[40]Paris D,Humphrey J,Quadros A,et al.Vasoactive effects of A beta in isolated human cerebrovessels and in a transgenic mouse model of Alzheimers disease:role of inflammation.Neurol Res,2003,25(6):642-651., 百拇医药(王彦喆,孙景旭)